cisplatin/cyclophosphamide/doxorubicin/tegafur protocol

Known as: Cisplatin/Cyclophosphamide/Doxorubicin/Tegafur, CDDP/CTX/DOX/FT, FACP protocol 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Alan J. Garber, MD, PhD, FACE1; Martin J. Abrahamson, MD2; Joshua I. Barzilay, MD, FACE3; Lawrence Blonde, MD, FACP, FACE4… (More)
  • table 1
Is this relevant?
Highly Cited
2015
Highly Cited
2015
Yehuda Handelsman, MD, FACP, FACE, FNLA1; Zachary T. Bloomgarden, MD, MACE2; George Grunberger, MD, FACP, FACE3; Guillermo… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2014
2014
W. Timothy Garvey, MD, FACE, Chair1; Alan J. Garber, MD, PhD, FACE2; Jeffrey I. Mechanick, MD, FACN, FACP, FACE, ECNU3; George A… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Alan J. Garber, MD, PhD, FACE; Martin J. Abrahamson, MD; Joshua I. Barzilay, MD, FACE; Lawrence Blonde, MD, FACP, FACE; Zachary T… (More)
  • table 1
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Alan J. Garber, MD, PhD, FACE; Martin J. Abrahamson, MD; Joshua I. Barzilay, MD, FACE; Lawrence Blonde, MD, FACP, FACE; Zachary T… (More)
  • table 1
Is this relevant?
2010
2010
A MESSAGE FROM ASCO'S PRESIDENT Since its founding in 1964, the American Society of Clinical Oncology (ASCO) has been committed… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2009
2009
Family caregivers play a major role in maximizing the health and quality of life of more than 30 million individuals with acute… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
John B. Holcomb, MD, FACS, Don Jenkins, MD, FACS, Peter Rhee, MD, FACS, Jay Johannigman, MD, FS, FACS, Peter Mahoney, FRCA, RAMC… (More)
Is this relevant?
1990
1990
Seventeen patients with recurrent or unresectable salivary gland carcinomas were treated with combination fluorouracil (5-FU… (More)
Is this relevant?